[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  $llys Eli Lilly faces legal setbacks while also experiencing competition in the weight-loss drug market. Positive financial metrics are offset by market volatility and trial disappointments, creating mixed narratives for the stock's performance right now. ### About $llys Analysis of social media sentiment and market data for the cryptocurrency $llys. ### Insights [#](/topic/$llys/insights) - $llys engagements is up XXXXXX% from the previous week. - $llys posts created is up XXXXXX% from the previous week. ### Engagements: XXX [#](/topic/$llys/interactions) ---  [Engagements 24-Hour Time-Series Raw Data](/topic/$llys/time-series/interactions.tsv) **Current Value**: XXX **Daily Average**: XXXXX **1 Week**: XXXXX +573% **1 Month**: XXXXX -XX% **1-Year High**: XXXXXX on 2025-06-23 **1-Year Low**: X on 2025-06-05 | Social Network | X | | -------------- | - | | Engagements | XXX | ### Mentions: X [#](/topic/$llys/posts_active) ---  [Mentions 24-Hour Time-Series Raw Data](/topic/$llys/time-series/posts_active.tsv) **Current Value**: X **Daily Average**: X **1 Month**: X -XX% **1-Year High**: XX on 2025-08-08 **1-Year Low**: X on 2025-05-21 | Social Network | X | | -------------- | - | | Mentions | XX | ### Creators: X [#](/topic/$llys/contributors_active) ---  [Creators 24-Hour Time-Series Raw Data](/topic/$llys/time-series/contributors_active.tsv) X unique social accounts have posts mentioning $llys in the last XX hours which is no change from in the previous XX hours **Daily Average**: X **1 Month**: X -XX% **1-Year High**: XX on 2025-08-08 **1-Year Low**: X on 2025-05-21 ### Sentiment: XX% [#](/topic/$llys/sentiment) ---  [Sentiment 24-Hour Time-Series Raw Data](/topic/$llys/time-series/sentiment.tsv) **Current Value**: XX% **Daily Average**: XX% **1 Month**: XX% -XX% **1-Year High**: XXX% on 2025-05-01 **1-Year Low**: XX% on 2025-06-22 **Most Supportive Themes** - **Positive Financial Performance:** (15%) Posts highlight Eli Lilly's rising Return on Capital, indicating positive financial performance. **Most Critical Themes** - **Legal Challenges and Competition:** (35%) Mentions of a dismissed lawsuit and competition with other pharmaceutical companies. Network engagement breakdown: | Network | Positive | % | Neutral | % | Negative | % | | ------- | -------- | - | ------- | - | -------- | - | | X | XXX | XX% | XXX | XX% | XX | X% | | | | | | | | | | Total | XXX | XX% | XXX | XX% | XX | X% | **Top assets mentioned** In the posts about $llys in the last XX hours [Novo-Nordisk (NVO)](/topic/$nvo) [Hims & Hers Health, Inc. (HIMS)](/topic/hims-hers) [Eli Lilly and Company (LLY)](/topic/eli-lilly) [Eli Lilly and Company (LLY)](/topic/$lly) [Hims & Hers Health, Inc. (HIMS)](/topic/$hims) **Top topics mentioned** In the posts about $llys in the last XX hours [stocks healthcare](/topic/stocks-healthcare), [$nvo](/topic/$nvo), [$nvos](/topic/$nvos), [hims hers](/topic/hims-hers), [stocks consumer defensive](/topic/stocks-consumer-defensive), [$barcl](/topic/$barcl), [$anab](/topic/$anab), [eli lilly](/topic/eli-lilly), [$lly](/topic/$lly), [$eqnrol](/topic/$eqnrol), [stocks](/topic/stocks), [$hims](/topic/$hims), [$isrgs](/topic/$isrgs), [drugs](/topic/drugs), [story of](/topic/story-of), [state of](/topic/state-of), [arizona](/topic/arizona), [targets](/topic/targets) ### Top Social Posts [#](/topic/$llys/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "$NVO's Ozempic and $LLY's Mounjaro are the talk of the pharmaceutical world" [X Link](https://x.com/YessicaZazueta/status/1978990160311202075) [@YessicaZazueta](/creator/x/YessicaZazueta) 2025-10-17T01:03Z X followers, XXX engagements "$LLY's success in weight-loss drugs has put it in direct competition with $NVO" [X Link](https://x.com/thetomofduty/status/1978989212075434489) [@thetomofduty](/creator/x/thetomofduty) 2025-10-17T00:59Z XX followers, XXX engagements "Then come back for day 2: AMA CEO Bobby Mukkamala onthe story of his own fight with brain cancer and the state of American medicine. An interview with $LLYs CSO Dan Skovronsky about obesity infectious disease and more. Go inside the upheaval at NIH with a panel that includes former NHGRI director Eric Green 6/8" [X Link](https://x.com/matthewherper/status/1978103590808899687) [@matthewherper](/creator/x/matthewherper) 2025-10-14T14:20Z 110K followers, 2144 engagements "Exciting lineup for the Best Healthcare Company. $HIMS continues to post impressive growth but watch for regulatory headwinds. $LLY's weight-loss meds are game-changers while $ISRGs innovative surgical tech is key for long-term value. $MCK is solid with strong revenue growth and $TMDX is showing promise in organ transplant innovation. Big potential across the board" [X Link](https://x.com/AskFinvest/status/1978014019748593687) [@AskFinvest](/creator/x/AskFinvest) 2025-10-14T08:24Z 1538 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Eli Lilly faces legal setbacks while also experiencing competition in the weight-loss drug market. Positive financial metrics are offset by market volatility and trial disappointments, creating mixed narratives for the stock's performance right now.
Analysis of social media sentiment and market data for the cryptocurrency $llys.
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
1 Week: XXXXX +573%
1 Month: XXXXX -XX%
1-Year High: XXXXXX on 2025-06-23
1-Year Low: X on 2025-06-05
Social Network | X |
---|---|
Engagements | XXX |
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
1 Month: X -XX%
1-Year High: XX on 2025-08-08
1-Year Low: X on 2025-05-21
Social Network | X |
---|---|
Mentions | XX |
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $llys in the last XX hours which is no change from in the previous XX hours
Daily Average: X
1 Month: X -XX%
1-Year High: XX on 2025-08-08
1-Year Low: X on 2025-05-21
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Month: XX% -XX%
1-Year High: XXX% on 2025-05-01
1-Year Low: XX% on 2025-06-22
Most Supportive Themes
Most Critical Themes
Network engagement breakdown:
Network | Positive | % | Neutral | % | Negative | % |
---|---|---|---|---|---|---|
X | XXX | XX% | XXX | XX% | XX | X% |
Total | XXX | XX% | XXX | XX% | XX | X% |
Top assets mentioned In the posts about $llys in the last XX hours
Novo-Nordisk (NVO) Hims & Hers Health, Inc. (HIMS) Eli Lilly and Company (LLY) Eli Lilly and Company (LLY) Hims & Hers Health, Inc. (HIMS)
Top topics mentioned In the posts about $llys in the last XX hours
stocks healthcare, $nvo, $nvos, hims hers, stocks consumer defensive, $barcl, $anab, eli lilly, $lly, $eqnrol, stocks, $hims, $isrgs, drugs, story of, state of, arizona, targets
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$NVO's Ozempic and $LLY's Mounjaro are the talk of the pharmaceutical world"
X Link @YessicaZazueta 2025-10-17T01:03Z X followers, XXX engagements
"$LLY's success in weight-loss drugs has put it in direct competition with $NVO"
X Link @thetomofduty 2025-10-17T00:59Z XX followers, XXX engagements
"Then come back for day 2: AMA CEO Bobby Mukkamala onthe story of his own fight with brain cancer and the state of American medicine. An interview with $LLYs CSO Dan Skovronsky about obesity infectious disease and more. Go inside the upheaval at NIH with a panel that includes former NHGRI director Eric Green 6/8"
X Link @matthewherper 2025-10-14T14:20Z 110K followers, 2144 engagements
"Exciting lineup for the Best Healthcare Company. $HIMS continues to post impressive growth but watch for regulatory headwinds. $LLY's weight-loss meds are game-changers while $ISRGs innovative surgical tech is key for long-term value. $MCK is solid with strong revenue growth and $TMDX is showing promise in organ transplant innovation. Big potential across the board"
X Link @AskFinvest 2025-10-14T08:24Z 1538 followers, XXX engagements
/topic/$llys